Myriad Genetics reported $-4700000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agilent A:US $ 264M 48M
Becton, Dickinson and BDX:US $ 525M 226M
Bio Rad Laboratories BIO:US $ 914.11M 63.3M
Biocept BIOC:US $ -1.83M 4.43M
Bruker BRKR:US $ 57.6M 0.9M
Danaher DHR:US $ 1785M 83M
Fluidigm FLDM:US $ -17.14M 1.68M
Genmark Diagnostics GNMK:US $ -3.72M 0.5M
Hologic HOLX:US $ 268.4M 351.5M
Illumina ILMN:US $ 185M 38M
Johnson & Johnson JNJ:US $ 6278M 81M
Luminex LMNX:US $ 9.08M 8.84M
Mettler Toledo International MTD:US 184.76M 35.1M
Myriad Genetics MYGN:US $ -4.7M 34.8M
Nanostring Technologies NSTG:US $ -27.02M 0.69M
Orasure Technologies OSUR:US $ -1.36M 5.14M
Oxford Immunotec Global OXFD:US $ -0.15M 9.54M
Pacific Biosciences Of California PACB:US $ -41M 46.43M
Perkinelmer PKI:US $ 245.93M 133.38M
Quest Diagnostics DGX:US $ 631M 162M
Quidel QDEL:US $ 19.07M 159.01M
Repligen RGEN:US $ 36.23M 6.78M
Thermo Fisher Scientific TMO:US $ 1828M 509M
Veracyte VCYT:US $ -9.04M 32.83M
Waters WAT:US $ 167.29M 19.16M